Market Place
Sourcing Support
All News #Library
Biotech
Genelux Corporation To Participate In Upcoming Conferences
18 Feb 2026 //
GLOBENEWSWIRE
Genelux Corp. To Host Virtual Fireside Chat With Titan Partners
12 Jan 2026 //
GLOBENEWSWIRE
Genelux Sets $20M Public Stock Offering Price
08 Jan 2026 //
GLOBENEWSWIRE
Genelux Shows Positive Interim Olvi-Vec Data In Lung Cancer
05 Jan 2026 //
GLOBENEWSWIRE
Genelux Corp Joins Fireside Chat At Piper Sandler Healthcare Conf
26 Nov 2025 //
GLOBENEWSWIRE
Genelux Corp. Unveils Q3 2025 Financials & Business Updates
05 Nov 2025 //
GLOBENEWSWIRE
Genelux Corporation Joins Chat at H.C. Wainwright Conference
02 Sep 2025 //
GLOBENEWSWIRE
Genelux Corporation Reports Q2 2025 Financials, Business Update
07 Aug 2025 //
GLOBENEWSWIRE
Genelux names Eric as General Counsel & Chief Compliance Officer
07 Jul 2025 //
GLOBENEWSWIRE
Genelux aligns with FDA on Olvi-Vec approval pathway for disease
25 Mar 2025 //
GLOBENEWSWIRE
Genelux Corporation Prices $10.5M Common Stock Offering
25 Mar 2025 //
GLOBENEWSWIRE
Genelux Corporation Announces New Chief Financial Officer
03 Feb 2025 //
GLOBENEWSWIRE
Genelux Corporation Reports Q3 2024 Financial Results & Updates
14 Nov 2024 //
GLOBENEWSWIRE
Genelux Doses First Patient In Phase 2 Trial For Lung Cancer
22 Oct 2024 //
GLOBENEWSWIRE
Genelux To Participate In BTIG Virtual Biotechnology Conference 2024
30 Jul 2024 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.